March 4

2018 CDC Advisory Committee Recommendations Re: DTaP Vaccine

Parents need to know the facts about vaccine safety issues, about which they are never informed; they are provided instead with propaganda. The CDC website and public health officials regularly misinform parents, doctors, the public, and Congress. The story line repeatedly recited in public by “authoritative” health officials, influential academic pediatricians, and the corporate media is an unyielding, faith-based mantra  proclaiming that “vaccines are perfectly safe”; “there is no link between vaccines and autism” or any irreversible neurological illness”.

These “authorities” disregard the scientific and empirical evidence that raise serious doubts about the safety of some vaccines and the lack of justification for subjecting  infants and young children to a battery of multiple vaccines administered simultaneously. The clustering of multiple vaccines serves to shield each vaccine from being identified as the cause of harm should harm occur.

And they pretend ignorance about a wide range severe adverse reactions following vaccination that the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) acknowledges in its report based on its evaluation of the evidence. ACIP reports “are intended for use by clinicians and public health providers”.  

The following excerpts are taken from the latest ACIP report about the diphtheria, tetanus, pertussis (a.k.a. whooping cough) vaccine,  issued in April 2018. This is the DTaP vaccine that contains 10 times higher toxin doses than the TdaP vaccine recommended for adults. The DTaP is  given to infants and young children in five doses; from the age of 2 months, 4 months, 6 months, 18 months and at age 5.

The ACIP panel acknowledges a wide range adverse reactions following vaccination – including potentially severe reactions:

Providers should screen patients for contraindications and precautions to the vaccine before each dose of vaccine is administered (Table 2).

A contraindication is a condition in a recipient that increases the risk for a serious adverse reaction. A vaccine should not be administered when a contraindication is present. ‘

Table 2: Contraindications for DTaP

  • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component†
    Encephalopathy (e.g., coma, decreased level of consciousness, or prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP or DTaP

  *Further vaccination with any of the three components of DTaP should    be deferred because of uncertainty as to which component of the vaccine  might be responsible. 

In contrast, certain conditions are commonly misperceived as contraindications (i.e., are not valid reasons to defer vaccination) (Table 3). 

Table 3: The DTaP vaccine that infants receive

Fever of <105°F (<40.5°C), fussiness or mild drowsiness after a previous dose of DTP/DTaP
Family history of seizures
Family history of sudden infant death syndrome
Family history of an adverse event after DTP or DTaP administration
Stable neurologic conditions (e.g., cerebral palsy, well-controlled seizures, or developmental delay)
History of collapse or shock-like state within 48 hours after receiving a previous dose of DTP/DTaP
History of seizure with or without fever within 3 days after receiving a previous dose of DTP/DTaP
History of persistent, inconsolable crying lasting >3 hours within 48 hours after receiving a previous dose of DTP/DTaP

“In general, vaccinations should be deferred when a precaution is present. However, a vaccination might be indicated in the presence of a precaution if the perceived benefit of protection from the vaccine outweighs the risk for an adverse reaction. For DTaP vaccines, providers”. 

 p. 14
During January 1, 1990–July 31, 2015, VAERS received 46,448 reports involving receipt of one of the five DTaP vaccines that are available in the United States during that period (Daptacel, Infanrix, Kinrix, Pediarix, and Pentacel);

44,061 (95%) of the reports involved children aged <6 years.

 Among all DTaP vaccine-related reports, 5,205 (11%) were coded as serious (i.e., one of the following outcomes was reported: death, life-threatening illness, hospitalization, prolongation of hospitalization, or permanent disability).

Adverse Events Associated with Vaccines with Pertussis Components or Tetanus Toxoid– Containing Components

During the whole-cell pertussis vaccine era, the Institute of Medicine (IOM) concluded that evidence favored acceptance of a causal relation between pediatric DTP use and acute encephalopathy.

After the change to DTaP vaccines [in 1996], IOM reviewed the evidence for a causal association between acellular pertussis–containing vaccines and several neurologic outcomes.  

The evidence was inadequate to accept or reject a causal relation between receipt of acellular pertussis-containing vaccine and encephalitis, encephalopathy, infantile spasms, seizures, ataxia, autism, acute disseminated encephalomyelitis, transverse myelitis, optic neuritis, onset of multiple sclerosis in adults, relapse of multiple sclerosis in adults, relapse of multiple sclerosis in children, Guillain-Barré syndrome, chronic inflammatory disseminated polyneuropathy, opsoclonus myoclonus syndrome, or Bell’s palsy.

The following conditions are considered precautions and not contraindications as indicated in DTaP package inserts: progressive neurologic disorders including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy.” (p. 43) 

Peter Aaby, MD, is both a medical doctor and anthropologist who has been conducting research on vaccine safety and efficacy. He established a surveillance system in West Africa, in 1978, an active surveillance system that monitors disease, vaccines, and health interventions. His team of researchers have conducted a series of “natural studies” of vaccinated and unvaccinated children in high-mortality regions in rural Africa. They have published more than 700 scientific articles. In 1991, he identified an unexpected phenomena: vaccines may trigger adverse health effects   not related to the targeted disease.

Dr. Peter Aaby

His seminal studies confirm that: “Though a vaccine protects children against the target disease, it may simultaneously increase susceptibility to unrelated infections.

It should be of concern that the effect of routine vaccinations on all-cause mortality was not tested in randomized trials. All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis.”
Evidence of Increase in Mortality After the Introduction of Diphtheria–Tetanus–Pertussis Vaccine to Children Aged 6–35 Months in Guinea-Bissau: A Time for Reflection? A Natural Experiment,” 2017)

Dr. Anthony Fauci,  is the longtime director of the National Institute of Allergies and Infectious Diseases at the National Institutes of Health, who is on record claiming that: “Risks from vaccines are almost nonmeasurable“.  On February 27, 2019, he testified before a congressional committee. When asked if a vaccine can cause  encephalitis — a serious risk of brain damage that is listed on vaccine insert disclosures —  Dr. Fauci lied, denying the risk. When parents of brain-damaged children gasped, he retracted and mumbled “in rare cases”.

So, whom do you trust to provide you with accurate information about vaccine safety and potential hazards?

An honest scientist who seeks to improve children’s health and survival or  powerful government bureaucrats who are tasked with disseminating propaganda to ensure high utilization of vaccines?


Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

November 21, 2023

Vera Sharav is joining Christine Anderson as special guest for the Make It Your Business event in

Read More
Vera Sharav Joins Christine Anderson for Make It Your Business – Dec 4, 2023 in New Jersey

November 21, 2023

Vera Sharav is premiering the movie Never Again is Now Global in New York City, December 1.

Read More
Never Again is Now Global – Premiere Screening – Dec 1, 2023 in New York City